4, 4, 6-Trimethyl-3, 4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-β-hydroxylation in vivo
- 31 January 1971
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 20 (1), 183-191
- https://doi.org/10.1016/0006-2952(71)90484-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- On the significance of central noradrenaline for motor activity: Experiments with a new dopamine β-hydroxylase inhibitorEuropean Journal of Pharmacology, 1969
- Effect of some N.N-disubstituted dithiocarbamates on catecholamines level in rat brainBiochemical Pharmacology, 1969
- Inhibition of dopamine β-hydroxylase by sulfhydryl compounds and the nature of the natural inhibitorsBiochimica et Biophysica Acta (BBA) - Enzymology, 1967
- Biochemical Mechanisms of Drug ActionAnnual Review of Pharmacology, 1967
- Phenylethyldithiocarbamate: a new dopamine-β-hydroxylase inhibitorJournal of Pharmacy and Pharmacology, 1967
- Restoration of the Response of the Isolated Atria of Guinea-Pigs to Tyramine and Possible Significance of β-HydroxylationNature, 1966
- Inhibition of dopamine-β-oxidase by dietbyldithiocarbamateJournal of Pharmacy and Pharmacology, 1965
- The inhibitionof dopamine-β-hydroxylase by tropolone and other chelating agentsBiochemical Pharmacology, 1964
- Inhibition of dopamine- β -hydroxylase by disulfiramLife Sciences, 1964
- The activation and inhibition of phenylamine-β-hydroxylaseCellular and Molecular Life Sciences, 1962